Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/HVIVO-PLC-61112301/attualita/HVIVO-firma-un-accordo-da-6-8-milioni-di-sterline-per-testare-il-candidato-farmaco-antivirale-RSV-42908298/?utm_source=whatsapp&utm_medium=social&utm_campaign=share